Could Novavax Have a Clinical Trial Mutiny on Its Hands?

No proof of vaccination, no travel. That's the reality for people in the United Kingdom. But for individuals in Novavax's (NASDAQ:NVAX) U.K. late-stage study of its COVID-19 vaccine, this reality has become a problem. Some study participants have even reportedly threatened to drop out of the clinical trial. In this Motley Fool Live video recorded on May 26, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Novavax could have a clinical trial mutiny on its hands.